Visual Impairment

Background

Patients Treated: over 500 (as of 2012)

Since 2007, Beike stem cells have been used in the treatment of patients with visual impairment. Previously treated conditions include (but are not limited to):

  • Optic Nerve Hypoplasia (ONH)
  • Septo-Optic Dysplasia (SOD) with ONH
  • Optic Nerve Atrophy (ONA)
  • Leber’s Hereditary Optic Neuropathy (LHON)
  • Retinitis Pigmentosa (RP)
  • Retinopathy of Prematurity (ROP)
  • Diabetic Retinopathy

Normal treatment protocol for visually impaired patients consists of umbilical cord blood-derived stem cells injected by IV and LP. Our partner hospital doctors are also performing retrobulbar injections for selected patients. This process involves injecting the stem cells into the retrobulbar space behind the eye socket. Our doctors can inform you after a medical review if this injection is an option for the treatment. There is the possibility of minimal/no improvement, and we encourage patients and caregivers to keep realistic expectations for the treatment.

General Treatment Protocol: Below is the general treatment protocol for patients with visual impairment. Please keep in mind that this is only an example and the injection and cell types may change slightly depending on the patient’s condition. Some patients may receive a direct retrobulbar injection (decided by the doctors upon medical review).

  • UCBSC packets injected by IV and LP
  • UCBSC packets injected by IV, LP, and 1 retrobulbar injection
  • Children with hormone problems may receive only IV

Submitting Medical Information: When submitting medical information (HERE) please note that our doctors do usually request to view certain medical documents to confirm the diagnosis. You should try to provide these at the same time or shortly after the medical form has been submitted. Note that you do not have to submit all of the documents below, just ones that are applicable for your condition.

  • Standard Documents: Test or doctor’s summary of a brain CT or MRI, VEP, ERG, Optometry/visual acuity, Fundus Photography / Fundus Examination. For SOD patients- Hormone levels (Thyroid stimulating hormone, Growth hormone, ACTH, Antidiuretic hormone)
  • If Applicable: Pupillometry, Optic Coherence Tomography (OCT), Contrast Sensitivity Testing, Peripheral Vision Testing, Fundus Fluorescein Angiography

…………………………………………………………………………………………………………………………………………..

Studies

Below is a link to the Descriptive Statistical Report on ONH/SOD Cases with Cell Therapy, a subjective follow-up study tracking patient improvements through the first year after treatment. You can view the PDF in your browser and save it to your computer.

Case studies focus on individual patients and detail their treatment and results. We will be updating this section with new case studies as they become available. Simply click on the pictures below to open each case study.

…………………………………………………………………………………………………………………………………………..

Past Patients Talk About Treatment In China

StemCellsChina was developed by several stem cell providers in China as a place for patients to candidly share real information about their treatment experiences through videos and non-moderated blogs. Beike supports the production of patient-focused video content for StemCellsChina. Patients and families are encouraged to share the nuts-and-bolts of their experiences while at the hospital and afterward.

Stem Cells China Patient Experience Pages

StemCellsChina hosts patient experience pages from past patients. These pages detail patients’ treatment journeys, including the condition before treatment, the treatment protocols the received, and after-treatment observations. These documents are either written by patients or edited together from comments patients recorded during interviews. You can click on the visual impairment conditions below to access the patient experience menus.

Stem Cells China Vimeo Channel

You can view all of StemCellsChina’s visual impairment-focused patient interview videos on this Vimeo channel. Simply click HERE to access the channel.

………………………………………………………………………………………………………………………………………….

Recent Patients

Below are direct links interviews and patient experience pages for a few recent patient.  We will update these as new content becomes available.

Lawrence Brown, USA, ONH, 17 years old (at time of treatment)

Before arriving for treatment, Lawrence only had some light perception and his doctors at home in the US told the family there was no treatment that could help him. After completing treatment here in China, he has started to see more defined objects from farther distances and has become more independent. You can find more information about Lawrence by clicking the picture below.

Shiu Sisters, Hong Kong, ROP and CP, 2 and 4 years old

Celia and Angelica both have CP. In addition, Angelica also has ROP. Angelica’s mother saw improvements in both her behavior and her vision.

Valerie Dolan, Ireland, ONA, 24 years old

Valerie can for treatment late last year and received 8 cell packets in total. After treatment, she observed that she could see more accurate colors and could read smaller print.

Lilli Mann, USA, ONH, 9 years old (at time of treatment)

Lilli arrived with her mother to Qingdao for a one month treatment at the end of 2009. Click below to access her patient experience page. The family did an interview with Stem Cells China while in Qingdao and the video can also be accessed from the below page.

News and Updates

We have just made available an updated Beike Information Guide and it can be viewed or downloaded from this site. Right click on the above link to save or click to open the full pdf. Please allow up to a minute after clicking on the link for the guide to fully download.

New case studies have been posted for Spinal Cord Injury, Ataxia, and Friedreich's Ataxia.

New case studies have been posted for Autism, Brain Injury, and Cerebral Palsy.

Please be aware that Beike has moved its headquarters. We are still located in Shenzhen's technology district but our new office brings our corporate headquarters and research laboratories under one roof. Our new address is as follows: East Block, 2nd Floor Yuanxing Technology Buliding #1 Songpingshan Road, Nanshan District Shenzhen, Guangdong, China

A new study has been posted for sensorineural hearing loss. The patient was a 4 years old boy. To see the study, click HERE.

5 new case studies have been uploaded to our Research and Studies Hub. These case studies are for ALS, cerebral palsy, ROP, hearing loss, and ischemic optic neuropathy.

A new case study has been posted in the Research and Studies Hub. The focus of this case study is visual impairment due to glaucoma. Click HERE to view the study.

The Journal Of Translational Medicine has just published Beike scientists' research on the treatment of hereditary ataxia with human umbilical cord-derived mononuclear cells and rehabilitation therapy. The research paper can be viewed HERE.

Two new case studies have been posted in the Research and Studies Hub. These retrospective studies are for ataxia and muscular dystrophy.

Three new case studies have been posted in the Research and Studies Hub. These retrospective studies are for brain injury, cerebral palsy, and macular degeneration.

We have now posted a fully translated version (English) of this news telecast to our new YouTube channel. As we have stated before, it was an amazing honor for China's Premier to visit Beike and caught many of us in the International Department by surprise. To have Premier Wen Jaibao decide to visit Beike specifically, in a country as big, as innovative, and as diverse as China just adds to our excitement. You can see the translated video HERE.